Literature DB >> 12871556

Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats.

A Sweatt1, D C Sane, S M Hutson, R Wallin.   

Abstract

The vitamin K-dependent protein, matrix Gla protein (MGP) is a binding protein for bone morphogenetic protein-2 (BMP-2). Here we present additional evidence that the Ca2+-induced conformer of the vitamin K-dependent Gla region in MGP is involved in BMP-2 binding. Recombinant BMP-2 binds to the Gla-containing region of MGP in the presence of Ca2+. Immunohistochemistry showed that calcified lesions in the aortic wall of aging rats contained elevated concentrations of MGP that was poorly gamma-carboxylated and did not bind BMP-2. In contrast, we were able to identify glandular structures in the mucosa of the rat nasal septum that gave bright fluorescent signals with both antigens; confocal microscopy confirmed their colocalization. These results demonstrate that the BMP-2/MGP complex exists in vivo, consistent with a role for MGP as a BMP-2 inhibitor. Age-related arterial calcification may be a consequence of under-gamma-carboxylation of MGP, allowing unopposed BMP-2 activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871556     DOI: 10.1046/j.1538-7836.2003.00023.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  42 in total

1.  The association of matrix Gla protein isomers with calcification in capsules surrounding silicone breast implants.

Authors:  Larry W Hunter; John C Lieske; Nho V Tran; Virginia M Miller
Journal:  Biomaterials       Date:  2011-08-11       Impact factor: 12.479

2.  Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification.

Authors:  Koba A Lomashvili; Xiaonan Wang; Reidar Wallin; W Charles O'Neill
Journal:  J Biol Chem       Date:  2011-06-24       Impact factor: 5.157

3.  Matrix GLA protein function in human trabecular meshwork cells: inhibition of BMP2-induced calcification process.

Authors:  Wei Xue; Reidar Wallin; Elizabeth A Olmsted-Davis; Teresa Borrás
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

4.  Epidemiology of osteoporosis.

Authors:  Laura Masi
Journal:  Clin Cases Miner Bone Metab       Date:  2008-01

5.  Circulating calcification inhibitors and vascular properties in children after renal transplantation.

Authors:  Marieke J H van Summeren; Jeroen M Hameleers; Leon J Schurgers; Arnold P G Hoeks; Cuno S P M Uiterwaal; Thilo Krüger; Cees Vermeer; Wietse Kuis; Marc R Lilien
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

Review 6.  The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complications.

Authors:  Katherine Wesseling-Perry; Harald Jüppner
Journal:  Bone       Date:  2012-10-16       Impact factor: 4.398

7.  Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification.

Authors:  Reidar Wallin; Leon Schurgers; Nadeem Wajih
Journal:  Thromb Res       Date:  2008-01-30       Impact factor: 3.944

Review 8.  Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression.

Authors:  Anna Csiszar; Stephanie Lehoux; Zoltan Ungvari
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

Review 9.  Regression of vascular calcification in chronic kidney disease - feasible or fantasy? a review of the clinical evidence.

Authors:  Oscar Leonard; Jonas Spaak; David Goldsmith
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

Review 10.  Chronic kidney disease: mineral and bone disorder in children.

Authors:  Katherine Wesseling-Perry; Isidro B Salusky
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.